Home › Pelvic Pain › NCT03794466
Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization
RecruitingObservational study
Quantification of Pain Relief With Gonadal Vein Embolization for Pelvic Congestion Syndrome
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Female patients 18 years of age or older * Meet the clinical and imaging criteria for the diagnosis of PCS and have no contraindications to coil embolization of the gonadal veins. * Patients who are treated with coil embolization of the gonadal veins in the Interventional Radiology division between October 1, 2018 to October 1, 2019. Exclusion Criteria: * Patients less than 18 years of age. * Patients who are found to have an underlying cause of pelvic congestion syndrome unrelated to venous congestion and insufficiency. This includes, but is not limited to, nutcracker syndrome, or a mass resulting in extrinsic compression of the gonadal veins. * Patients who have received prior surgical therapy for PCS, including bilateral salpingo-oophorectomy (TAH-BSO), gonadal vein resection, or gonadal vein ligation.
About the study
The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a positive response to treatment, or poor response to treatment.
Sponsor: University of Kansas Medical Center · Participants: 30 · Started: May 10, 2019
Contact the study team
- Carissa Walter, MPH · Phone: 9139457450
Official record on ClinicalTrials.gov — NCT03794466
Locations in the U.S.
| Kansas | The University of Kansas Medical Center, Kansas City |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.